{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T21:08:26Z","timestamp":1767992906807,"version":"3.49.0"},"publisher-location":"Cham","reference-count":47,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319100111","type":"print"},{"value":"9783319100128","type":"electronic"}],"license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014]]},"DOI":"10.1007\/5584_2014_50","type":"book-chapter","created":{"date-parts":[[2014,9,24]],"date-time":"2014-09-24T15:15:32Z","timestamp":1411571732000},"page":"13-24","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Inhalation of Macrolides: A Novel Approach to Treatment of Pulmonary Infections"],"prefix":"10.1007","author":[{"given":"R.","family":"Siekmeier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Hofmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Scheuch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,9,25]]},"reference":[{"key":"50_CR1","doi-asserted-by":"crossref","unstructured":"Albert RK, Connett J, Bailey WC, Casaburi R, Cooper JAD, Criner GJ, Curtis JL, Dransfield MT, Han MK, Lazarus SC, Make B, Marchetti N, Martinez FJ, Madinger NE, McEvoy C, Niewoehner DE, Porsasz J, Price CS, Reilly J, Scanlon PD, Sciurba FC, Scharf SM, Washko GR, Woodruff PG, Anthonisen NR, for COPD Clinical Research Network (2011) Azithromycin for prevention of exacerbations of COPD. N Engl J Med 365:689\u2013698","DOI":"10.1056\/NEJMoa1104623"},{"key":"50_CR2","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1159\/000320319","volume":"81","author":"J Altenburg","year":"2011","unstructured":"Altenburg J, de Graaf CS, van der Werf TS, Boersma WG (2011a) Immunomodulatory effects of macrolide antibiotics \u2013 Part 1: Biological mechanisms. Respiration 81:67\u201374","journal-title":"Respiration"},{"key":"50_CR3","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1159\/000320320","volume":"81","author":"J Altenburg","year":"2011","unstructured":"Altenburg J, de Graaf CS, van der Werf TS, Boersma WG (2011b) Immunomodulatory effects of macrolide antibiotics \u2013 Part 2: Advantages and disadvantages of long-term, low-dose macrolide therapy. Respiration 81:75\u201387","journal-title":"Respiration"},{"key":"50_CR4","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1001\/jama.2013.1937","volume":"309","author":"J Altenburg","year":"2013","unstructured":"Altenburg J, de Graaf CS, Stienstra Y, Sloos JH, van Haren EHJ, Koppers RJH, van der Werf TS, Boersma WG (2013) Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis. The BAT Randomized Controlled Trial. JAMA 309:1251\u20131259","journal-title":"JAMA"},{"issue":"52","key":"50_CR5","first-page":"1","volume":"2011","author":"D Bilton","year":"2011","unstructured":"Bilton D, Jones AL (2011) Bronchiectasis: epidemiology and causes. Eur Respir Monogr 2011(52):1\u201310","journal-title":"Eur Respir Monogr"},{"key":"50_CR6","unstructured":"Brodt HR, Smollich M, Stille W et al (2013) Antibiotika-Therapie. Klinik und Praxis der antiinfekti\u00f6sen Behandlung. Schattauer GmbH, Stuttgart. ISBN-13: 9783794525744"},{"key":"50_CR7","first-page":"239","volume":"52","author":"PT Bye","year":"2011","unstructured":"Bye PT, Lau EMT, Elkins MR (2011) Pharmacological airway clearance strategies in bronchiectasis. Eur Respir Monogr 52:239\u2013247","journal-title":"Eur Respir Monogr"},{"key":"50_CR8","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0014-2999(01)01321-8","volume":"429","author":"O Culic","year":"2001","unstructured":"Culic O, Erakovic V, Parnham MJ (2001) Anti-inflammatory effects of macrolide antibiotics. Eur J Pharmacol 429:209\u2013229","journal-title":"Eur J Pharmacol"},{"key":"50_CR9","unstructured":"Cystic Fibrosis Foundation (2012) Cystic Fibrosis Foundation patient registry annual data report 2011. Cystic Fibrosis Foundation. Bethesda, MD. http:\/\/www.cff.org\/UploadedFiles\/research\/ClinicalResearch\/2011-Patient-Registry.pdf. Accessed 6 Jan 2014"},{"key":"50_CR10","first-page":"32","volume":"52","author":"M Drain","year":"2011","unstructured":"Drain M, Elborn JS (2011) Assessment and investigation of adults with bronchiectasis. Eur Respir Monogr 52:32\u201343","journal-title":"Eur Respir Monogr"},{"key":"50_CR11","first-page":"68","volume":"52","author":"JE Foweraker","year":"2011","unstructured":"Foweraker JE, Wat D (2011) Microbiology of non-CF bronchiectasis. Eur Respir Monogr 52:68\u201396","journal-title":"Eur Respir Monogr"},{"key":"50_CR12","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1164\/rccm.200304-505SO","volume":"168","author":"RL Gibson","year":"2003","unstructured":"Gibson RL, Burns JL, Ramsey BW (2003) Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med 168:918\u2013951","journal-title":"Am J Respir Crit Care Med"},{"key":"50_CR13","unstructured":"Global Initiative for Chronic Obstructive Lung Disease: Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease (2013) http:\/\/www.goldcopd.org\/uploads\/users\/files\/GOLD_Report_2013_Feb20.pdf. Accessed 6 Jan 2014"},{"key":"50_CR14","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1517\/17425247.3.1.71","volume":"3","author":"JK Hagerman","year":"2006","unstructured":"Hagerman JK, Hancock KE, Klepser ME (2006) Aerosolised antibiotics: a critical appraisal of their use. Expert Opin Drug Deliv 3:71\u201386","journal-title":"Expert Opin Drug Deliv"},{"key":"50_CR15","first-page":"211","volume":"52","author":"CS Haworth","year":"2011","unstructured":"Haworth CS (2011) Antibiotic treatment strategies in adults with bronchiectasis. Eur Respir Monogr 52:211\u2013222","journal-title":"Eur Respir Monogr"},{"key":"50_CR16","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1089\/jam.2006.19.54","volume":"19","author":"AJ Hickey","year":"2006","unstructured":"Hickey AJ, Lu D, Ashley ED, Stout J (2006) Inhaled azithromycin therapy. J Aerosol Med 19:54\u201360","journal-title":"J Aerosol Med"},{"key":"50_CR17","doi-asserted-by":"publisher","first-page":"683","DOI":"10.2174\/138161212799315975","volume":"18","author":"T Hofmann","year":"2012","unstructured":"Hofmann T (2012) New developments in inhaled antibiotics for the treatment of Pseudomonas aeruginosa. Curr Pharm Des 18:683\u2013695","journal-title":"Curr Pharm Des"},{"key":"50_CR18","doi-asserted-by":"crossref","unstructured":"Hoppentocht M, Hagedoorn P, Frijlink HW, de Boer AH (2013) Development and strategies for inhaled antibiotic drugs in tuberculosis therapy: a critical evaluation. Eur J Pharm Biopharm 86:23\u201330","DOI":"10.1016\/j.ejpb.2013.10.019"},{"key":"50_CR20","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.2165\/11318500-000000000-00000","volume":"69","author":"AM Jones","year":"2009","unstructured":"Jones AM, Helm JM (2009) Emerging treatments in cystic fibrosis. Drugs 69:1903\u20131910","journal-title":"Drugs"},{"key":"50_CR21","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1128\/CMR.00078-09","volume":"23","author":"S Kanoh","year":"2010","unstructured":"Kanoh S, Rubin BK (2010) Mechanisms of action and clinical application of macrolides as immunomodulatory medications. Clin Microbiol Rev 23:590\u2013615","journal-title":"Clin Microbiol Rev"},{"key":"50_CR22","first-page":"632","volume":"25","author":"S Kudoh","year":"1987","unstructured":"Kudoh S, Uetake T, Hagiwara K, Hirayama M, Hus LH, Kimura H, Sugiyama Y (1987) Clinical effects of low-dose long-term erythromycin chemotherapy on diffuse panbronchiolitis. Nihon Kyobu Shikkan Gakkai Zasshi 25:632\u2013642 (in Japanese)","journal-title":"Nihon Kyobu Shikkan Gakkai Zasshi"},{"key":"50_CR23","first-page":"11","volume":"52","author":"BN Lambrecht","year":"2011","unstructured":"Lambrecht BN, Neyt K, GeurtsvanKessel CH (2011) Pulmonary defence mechanisms and inflammatory pathways in bronchiectasis. Eur Respir Monogr 52:11\u201321","journal-title":"Eur Respir Monogr"},{"key":"50_CR24","first-page":"248","volume":"52","author":"DC Mauchley","year":"2011","unstructured":"Mauchley DC, Mitchell JD (2011) Surgery for bronchiectasis. Eur Respir Monogr 52:248\u2013257","journal-title":"Eur Respir Monogr"},{"key":"50_CR25","doi-asserted-by":"crossref","unstructured":"McCormick J, Mehta G, Olesen HV, Viviani L, Macek M, Mehta A, on behalf of the European Registry Working Group (2010) Comparative demographics of the European cystic fibrosis population: a cross-sectional data base analysis. Lancet 375:1007\u20131013","DOI":"10.1016\/S0140-6736(09)62161-9"},{"key":"50_CR26","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1097\/GIM.0b013e31818e55a2","volume":"10","author":"SM Moskowitz","year":"2008","unstructured":"Moskowitz SM, Chmiel JF, Sternen DL, Cheng E, Gibson RL, Marshall SG, Cutting GR (2008) Clinical practice and genetic counseling for cystic fibrosis and CFTR-related disorders. Genet Med 10:851\u2013858","journal-title":"Genet Med"},{"key":"50_CR27","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/S0140-6736(96)07493-4","volume":"349","author":"CJL Murray","year":"1997","unstructured":"Murray CJL, Lopez AD (1997) Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 349:1269\u20131276","journal-title":"Lancet"},{"key":"50_CR28","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1056\/NEJMra1201534","volume":"369","author":"CJL Murray","year":"2013","unstructured":"Murray CJL, Lopez AD (2013) Measuring the global burden of disease. N Engl J Med 369:448\u2013457","journal-title":"N Engl J Med"},{"key":"50_CR29","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1007\/s11095-009-9957-4","volume":"26","author":"P Muttil","year":"2009","unstructured":"Muttil P, Wang C, Hickey AJ (2009) Inhaled drug delivery for tuberculosis therapy. Pharm Res 26:2401\u20132416","journal-title":"Pharm Res"},{"key":"50_CR30","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1159\/000029329","volume":"66","author":"LP Nicod","year":"1999","unstructured":"Nicod LP (1999) Pulmonary defense mechanisms. Respiration 66:2\u201311","journal-title":"Respiration"},{"key":"50_CR31","doi-asserted-by":"crossref","unstructured":"Pauwels RA, Buist AS, Calverley PMA, Jenkins CR, Hurd SS, on behalf of the GOLD Scientific Committee (2001) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI\/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop Summary. Am J Respir Crit Care Med 163:1256\u20131276","DOI":"10.1164\/ajrccm.163.5.2101039"},{"key":"50_CR32","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1002\/jps.23525","volume":"102","author":"G Pilcer","year":"2013","unstructured":"Pilcer G, Rosiere R, Traina K, Sebti T, Vanderbist F, Amighi K (2013) New co-spray-dried tobramycin nano-particles-clarithromycin inhaled powder systems for lung infection therapy in cystic fibrosis patients. J Pharm Sci 102:1836\u20131846","journal-title":"J Pharm Sci"},{"key":"50_CR33","first-page":"809","volume":"108","author":"J Rademacher","year":"2011","unstructured":"Rademacher J, Welte T (2011) Bronchiectasis: diagnosis and treatment. Deutsches \u00c4rzteblatt Int 108:809\u2013815","journal-title":"Deutsches \u00c4rzteblatt Int"},{"key":"50_CR34","unstructured":"Scheuch G, Siekmeier R (2007) Novel approaches to enhance pulmonary delivery of proteins and peptides. J Physiol Pharmacol 58(Suppl. 5):615\u2013625"},{"key":"50_CR35","first-page":"223","volume":"52","author":"DJ Smith","year":"2011","unstructured":"Smith DJ, Chang AB, Bell SC (2011) Anti-inflammatory therapies in bronchiectasis. Eur Respir Monogr 52:223\u2013238","journal-title":"Eur Respir Monogr"},{"key":"50_CR36","first-page":"601","volume":"68","author":"K Sollohub","year":"2011","unstructured":"Sollohub K, Janczyk M, Kutyla A, Wosicka H, Ciosek P, Cal K (2011) Taste masking of roxithromycin by spray drying technique. Acta Pol Pharm 68:601\u2013604","journal-title":"Acta Pol Pharm"},{"key":"50_CR38","doi-asserted-by":"publisher","first-page":"861","DOI":"10.3109\/03639040903551319","volume":"36","author":"K Togami","year":"2010","unstructured":"Togami K, Chono S, Seki T, Morimoto K (2010) Aerosol-based efficient delivery of telithromycin, a ketolide antimicrobial agent, to lung epithelial lining fluid and alveolar macrophages for treatment of respiratory infections. Drug Dev Ind Pharm 36:861\u2013866","journal-title":"Drug Dev Ind Pharm"},{"key":"50_CR39","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1089\/jamp.2011.0894","volume":"25","author":"K Togami","year":"2012","unstructured":"Togami K, Chono S, Morimoto K (2012) Aerosol-based efficient delivery of clarithromycin, a macrolide antimicrobial agent, to lung epithelial lining fluid and alveolar macrophages for treatment of respiratory infections. J Aerosol Med Pulmon Drug Deliv 25:110\u2013115","journal-title":"J Aerosol Med Pulmon Drug Deliv"},{"key":"50_CR40","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.3109\/10837450.2012.705296","volume":"18","author":"K Togami","year":"2013","unstructured":"Togami K, Chono S, Morimoto K (2013) Aerosol-based efficient delivery of azithromycin to alveolar macrophages for treatment of respiratory infections. Pharm Dev Technol 18:1361\u20131365","journal-title":"Pharm Dev Technol"},{"key":"50_CR41","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1517\/17425240903110710","volume":"6","author":"D Traini","year":"2009","unstructured":"Traini D, Young PM (2009) Delivery of antibiotics to the respiratory tract: an update. Expert Opin Drug Deliv 6:897\u2013905","journal-title":"Expert Opin Drug Deliv"},{"key":"50_CR42","doi-asserted-by":"publisher","first-page":"4409","DOI":"10.1128\/AAC.00372-10","volume":"54","author":"M Tre-Hardy","year":"2010","unstructured":"Tre-Hardy M, Nagant C, El Manssouri N, Vanderbist F, Traore H, Vaneechoutte M, Dehaye JP (2010) Efficacy of the combination of tobramycin and a macrolide in an in vitro Pseudomonas aeruginosa mature biofilm model. Antimicrob Agents Chemother 54:4409\u20134415","journal-title":"Antimicrob Agents Chemother"},{"key":"50_CR43","first-page":"CD010257","volume":"12","author":"DJ Vollenweider","year":"2012","unstructured":"Vollenweider DJ, Jarrett H, Steurer-Stey CA, Garcia-Aymerich J, Puhan MA (2012) Antibiotics for exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 12:CD010257","journal-title":"Cochrane Database Syst Rev"},{"key":"50_CR44","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1056\/NEJMct1115170","volume":"367","author":"RP Wenzel","year":"2012","unstructured":"Wenzel RP, Fowler AA, Edmond MB (2012) Antibiotic prevention of acute exacerbations of COPD. N Engl J Med 367:340\u2013347","journal-title":"N Engl J Med"},{"key":"50_CR45","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/S0140-6736(12)60953-2","volume":"380","author":"C Wong","year":"2012","unstructured":"Wong C, Jayaram L, Karalus N, Eaton T, Tong C, Hochey H, Milne D, Fergusson W, Tuffery C, Sexton P, Storey L, Ashton T (2012) Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial. Lancet 380:660\u2013667","journal-title":"Lancet"},{"key":"50_CR46","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1159\/000350828","volume":"86","author":"G-Y Yao","year":"2013","unstructured":"Yao G-Y, Ma Y-L, Zhang M-Q, Gao Z-C (2013) Macrolide therapy decreases chronic obstructive pulmonary disease exacerbation: a meta-analysis. Respiration 86:254\u2013260","journal-title":"Respiration"},{"key":"50_CR47","doi-asserted-by":"publisher","unstructured":"Yawn BP (2012) Is \u2018GOLD\u2019 standard for the management of COPD in clinical practice? Drugs Context 2012:212243. doi: 10.7573\/dic.212243. eCollection 2012","DOI":"10.7573\/dic.212243"},{"key":"50_CR48","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.2147\/DDDT.S51303","volume":"7","author":"P Zarogoulidis","year":"2013","unstructured":"Zarogoulidis P, Kioumis I, Porpodis K, Spyratos D, Tsakiridis K, Huang H, Li Q, Turner JF, Browning R, Hohenforst-Schmidt W, Zarogoulidis K (2013) Clinical experimentation with aerosol antibiotics: current and future methods for administration. Drug Des Dev Ther 7:1115\u20131134","journal-title":"Drug Des Dev Ther"},{"key":"50_CR49","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.ijpharm.2010.05.043","volume":"395","author":"Y Zhang","year":"2010","unstructured":"Zhang Y, Wang X, Lin X, Liu X, Tian B, Tang X (2010) High azithromycin loading powders for inhalation and their in vivo evaluation in rats. Int J Pharm 395:205\u2013214","journal-title":"Int J Pharm"}],"container-title":["Advances in Experimental Medicine and Biology","Inflammatory Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/5584_2014_50","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T03:38:44Z","timestamp":1675827524000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/5584_2014_50"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"ISBN":["9783319100111","9783319100128"],"references-count":47,"URL":"https:\/\/doi.org\/10.1007\/5584_2014_50","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]},"assertion":[{"value":"25 September 2014","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}